Lobe Sciences (Lobe Sciences) Change In Inventory : $0.00 Mil (TTM As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Lobe Sciences Change In Inventory?

Lobe Sciences's change in inventory for the quarter that ended in Feb. 2024 was $0.00 Mil. It means Lobe Sciences's inventory stayed the same from Nov. 2023 to Feb. 2024 .

Lobe Sciences's change in inventory for the fiscal year that ended in Aug. 2023 was $0.02 Mil. It means Lobe Sciences's inventory declined by $0.02 Mil from Aug. 2022 to Aug. 2023 .

Lobe Sciences's Total Inventories for the quarter that ended in Feb. 2024 was $0.01 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Lobe Sciences's Inventory Turnover for the quarter that ended in Feb. 2024 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lobe Sciences Change In Inventory Historical Data

The historical data trend for Lobe Sciences's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Change In Inventory Chart

Lobe Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Change In Inventory

Get a 7-Day Free Trial

0.02

Lobe Sciences Quarterly Data
	Dec18	Mar19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Lobe Sciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Lobe Sciences (OTCPK:LOBEF) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Lobe Sciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0.011	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Lobe Sciences's Inventory Turnover for the quarter that ended in Feb. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0.011
	=	0.00

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Lobe Sciences's Inventory to Revenue for the quarter that ended in Feb. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.011	/	0
	=	N/A

Lobe Sciences Change In Inventory Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences (Lobe Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (OTCPK:LOBEF) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

6YX0:Germany LOBE:Canada

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.